Clinical trial
NIV for Hypercapnic Respiratory Failure: AVAPS vs S/T BIPAP
NCT06047405 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NIV for Hypercapnic Respiratory Failure: AVAPS vs S/T BIPAP
- Lead sponsor
- Northwell Health
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 7, 2023
- Completion date
- September 1, 2026
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypercapnic respiratory failure